We are live on ! Find out more
APTO

Aptose Biosciences, Inc.
APTO

Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

13 hedge funds and large institutions have $2.48M invested in Aptose Biosciences, Inc. in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 12 → 13 (+1)

32% less capital invested

Capital invested by funds: $3.67M → $2.48M (-$1.18M)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$28.2K
2
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$7.17K
3
Jane Street
Jane Street
New York
+$3.08K
4
Creative Planning
Creative Planning
Kansas
+$1.02K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$359K
2
TSS
Two Sigma Securities
New York
-$24K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$16.9K
4
Bank of America
Bank of America
North Carolina
-$5.13K
5
TRCT
Tower Research Capital (TRC)
New York
-$1.02K
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$1.34M – – –
CAM
2
Cormorant Asset Management
Massachusetts
$1.01M – – –
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$33K -$512 -1 -1%
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$30K -$16.9K -33 -34%
Renaissance Technologies
5
Renaissance Technologies
New York
$25K +$28.2K +55 New
Jane Street
6
Jane Street
New York
$14K +$3.08K +6 +25%
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$9.7K +$10.8K +21 New
Morgan Stanley
8
Morgan Stanley
New York
$6K – – –
Parallax Volatility Advisers
9
Parallax Volatility Advisers
California
$6K +$7.17K +14 New
UBS Group
10
UBS Group
Switzerland
$2K – – –
Deutsche Bank
11
Deutsche Bank
Germany
$1K – – –
Creative Planning
12
Creative Planning
Kansas
$1K +$1.02K +2 New
BBA
13
Baker Bros. Advisors
New York
– -$359K -574 Closed
TSS
14
Two Sigma Securities
New York
– -$24K -38 Closed
Bank of America
15
Bank of America
North Carolina
– -$5.13K -10 -91%
TRCT
16
Tower Research Capital (TRC)
New York
– -$1.02K -2 Closed

APTO Hedge Fund Activity: Q1 2017 in Review

13 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q1 2017, worth a combined $2.48M — down 32% from $3.67M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new APTO positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $28.2K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $359K sold.

  • 13 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q1 2017, up from 12 in Q4 2016.
  • Funds reported $2.48M of Aptose Biosciences, Inc. stock for Q1 2017, down 32% quarter-over-quarter.
  • 4 funds opened new Aptose Biosciences, Inc. positions in Q1 2017 and 3 closed out, a net change of +1 holder.
  • The largest Aptose Biosciences, Inc. buyer in Q1 2017 was Renaissance Technologies, an estimated $28.2K added.
  • The largest Aptose Biosciences, Inc. seller in Q1 2017 was Baker Bros. Advisors, an estimated $359K sold.

Based on aggregated 13F filings for Q1 2017.